Specific information and usage of acotinib/concosine capsules
Acalabrutinib (Acalabrutinib) is a highly selective Bruton's tyrosine kinase (BTK) inhibitor mainly used to treat B cell-related hematological malignancies. BTK plays a central role in the B cell receptor signaling pathway. Abnormal activation can lead to abnormal proliferation and survival of B cells, eventually leading to diseases such as chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), and mantle cell lymphoma (MCL). By inhibiting BTK activity, acotinib effectively blocks these abnormal signaling pathways, thereby controlling disease progression and improving patients' quality of life.
Kangkeqi is provided in the form of capsules. The common specifications are:100mg, 8 capsules and 7 tablets. It is convenient to take orally and is suitable for long-term maintenance treatment. The standard adult dose is 100 mg twice daily, taken orally with water. The drug can be taken with food or on an empty stomach, but the interval between the two doses must be approximately equal to maintain stable blood concentration. During treatment, hematological indicators, liver and kidney function, and blood pressure changes need to be monitored regularly to detect and deal with adverse reactions in a timely manner.
Acotinib is metabolized mainly through the liverCYP3A pathway. Therefore, when using combined drugs, attention should be paid to potential drug interactions to avoid affecting blood concentration or efficacy. For patients using the medicine for a long time, ensure that the medicine is stored under appropriate conditions and avoid high temperature, humidity and direct sunlight to ensure the stability and efficacy of the medicine.
Clinical practice shows that acotinib has good efficacy and controllable tolerability. Compared with the first generationBTK inhibitor, it has a lower incidence of cardiovascular adverse events and can maintain disease control for a long time. By standardizing medication and follow-up management, patients can safely and continuously take Kangcoxi in a home environment to achieve precise treatment.
Reference materials:https://www.calquence.com/
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)